The negative regulation of circulating GDF15 during weight loss therapy is of particular interest, due to its regulatory role in nutritional behavior and potential implications for obesity therapy [31], as well as its association with NAFLD [23]. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.